Today, the US FDA commented on Paclitaxel devices in #PAD “the benefits continue to outweigh the risks” for approved Ptx coated balloons & Ptx eluting stents when used in accordance with their IFU. More data to be available soon https://t.co/FLGayxwP96
Increased awareness needed of gender differences in CV symptoms, treatment, as well as confronting potential treatment bias #ACC17 https://t.co/J0fesLiQMg